Journal of Nuclear Medicine Radiology & Radiation Therapy Category: Medical Type: Editorial
18F-FDG-PET/CT Imaging in Leukemia
- Manas Kumar Sahoo1*, Smeeta Gajendra2
- 1 Department Of Nuclear Medicine, All India Institute Of Medical Sciences (AIIMS), New Delhi-110029, India
- 2 Department Of Pathology And Laboratory Medicine, Medanta-The Medicity, Sector - 38, Gurgaon, Haryana, India
*Corresponding Author:Manas Kumar Sahoo
Department Of Nuclear Medicine, All India Institute Of Medical Sciences (AIIMS), New Delhi-110029, India
Received Date: Apr 25, 2016 Accepted Date: Apr 29, 2016 Published Date: May 14, 2016
Leukemia’s are characterized by diffuse replacement of bone marrow with proliferating leukemic cells with circulating immature white blood cells in the blood and widespread infiltrates in the liver, spleen, lymph nodes and other sites throughout the body. Leukemia’s are classified as acute or chronic and lymphoid or myeloid.
PET/CT IN ACUTE LEUKEMIA
PET/CT IN CHRONIC LEUKEMIA
There are few limitations of 18F- FDG PET-CT. FDG is not a very tumor-specific substance, in as much as the leukocytes and macrophages of inflammatory processes also accumulate the tracer which is a major source of false-positive diagnoses in the application of FDG-PET in oncology. Diffuse bone marrow uptake in FDG PET/CT may be due to an inflammatory reaction, recent chemotherapy or administration of hematopoietic growth factors/ colony stimulating factor. To reduce the potentially negative impact of occasional false-positive FDG-PET results on patient management, it is absolutely mandatory to carefully select the candidates for an FDG-PET scan to wait 8-10 weeks after surgery,10-12 weeks after local RT and 4-6 weeks after chemotherapy before an FDG PET scan is done.
To conclude, FDG PET/CT is useful in diagnosis and follow-up of patients with bone marrow malignancy.18F-FDG PET/CT may be useful for guiding the site of BM aspiration in cases with localized bone marrow involvement. It has an important role in diagnosing extra-medullary disease in de novo or relapsed AML patients. It can guide a diagnostic biopsy and may also provide prognostic information in patients with CLL. It is also useful in detection of Richter's transformation in CLL cases. Possibility of leukemia in known case of solid malignancies also kept in mind in follow up cases in which diffuse marrow uptake may be misinterpreted as chemotherapy effect or bone marrow metastasis by solid tumors. Bone marrow aspiration/biopsy must be performed for correct diagnosis and early management.
- Townsend DW (2008) Combined positron emission tomography-computed tomography: the historical perspective. Semin Ultrasound CT MR 29: 232-235.
- Seam P, Juweid ME, Cheson BD (2007) The role of FDG-PET scans in patients with lymphoma. Blood 110: 3507-3516.
- Endo T, Sato N, Koizumi K, Nishio M, Fujimoto K, et al. (2004) Localized relapse in bone marrow of extremities after allogeneic stem cell transplantation for acute lymphoblastic leukemia. Am J Hematol 76: 279-282.
- Ennishi D, Maeda Y, Niiya M, Shinagawa K, Tanimoto M (2009) Incidental detection of acute lymphoblastic leukemia on [18F]fluorodeoxyglucose positron emission tomography. J Clin Oncol 27: e269-270.
- Kuenzle K, Taverna C, Steinert HC (2002) Detection of extramedullary infiltrates in acute myelogenous leukemia with whole-body positron emission tomography and 2-deoxy-2-[18F]-fluoro-D-glucose. Mol Imaging Biol 4: 179-183.
- Stölzel F, Röllig C, Radke J, Mohr B, Platzbecker U, et al. (2011) 18F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia. Haematologica 96: 1552-1556.
- Falchi L, Keating MJ, Marom EM, Truong MT, Schlette EJ, et al. (2014) Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia. Blood 123: 2783-2790.
- Conte MJ, Bowen DA, Wiseman GA, Rabe KG, Slager SL, et al. (2014) Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Lymphoma 55: 2079-2084.
- Papajík T, Myslivecek M, Urbanová R, Buriánková E, Kapitánová Z, Procházka V, et al. (2014) 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation. Leuk Lymphoma 55: 314-319.
- Mauro FR, Chauvie S, Paoloni F, Biggi A, Cimino G, et al. (2015). Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease. Leukemia 2015 29: 1360-1365.
- Nakajo M, Jinnouchi S, Inoue H, Otsuka M, Matsumoto T, et al. (2007) FDG PET findings of chronic myeloid leukemia in the chronic phase before and after treatment. Clin Nucl Med 32: 775-778.
- Varoglu E, Kaya B, Sari O (2013) Chronic myeloid leukemia detected on FDG PET/CT imaging in a patient with renal cell carcinoma. Rev Esp Med Nucl Imagen Mol 32: 43-45.
- Ennishi D, Maeda Y, Niiya M, Shinagawa K, Tanimoto M (2009) Incidental detection of acute lymphoblastic leukemia on [18F]fluorodeoxyglucose positron emission tomography. J Clin Oncol 27: 269-270.
- Maeda T, Kosugi S, Ujiie H, Osumi K, Fukui T, et al. (2003) Localized relapse in bone marrow in a posttransplantation patient with t(6;9) acute myeloid leukemia. Int J Hematol 77: 522-525.
- Arimoto MK, Nakamoto Y, Nakatani K, Ishimori T, Yamashita K, et al. (2015) Increased bone marrow uptake of 18F-FDG in leukemia patients: preliminary findings. Springerplus 4: 521.
- Vanderhoek M, Juckett MB, Perlman SB, Nickles RJ, Jeraj R (2011) Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging. Leuk Res 35: 310-316.
- Tan G, Aslan A, Tazeler Z (2016) FDG-PET/CT for detecting relapse in patients with acute lymphoblastic leukemia. Jpn J Clin Oncol 46: 96-97.
- Cunningham I, Kohno B (2016) (18) FDG-PET/CT: 21st century approach to leukemic tumors in 124 cases.Am J Hematol 91: 379-384.
- Tsukamoto S, Ota S, Ohwada C, Takeda Y, Takeuchi M, et al. (2013) Extramedullary blast crisis of chronic myelogenous leukemia as an initial presentation. Leuk Res Rep 2: 67-69.
Citation:Sahoo MK, Gajendra S (2016) 18 F-FDG-PET/CT Imaging in Leukemia. J Nucl Med Radiol Radiat Ther 1: 003.
Copyright: © 2016 Manas Kumar Sahoo, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.